HLN

Haleon PLC (LSE:HLN, NYSE:HLN) received a Deutsche Bank upgrade despite a target cut, while RBC lowered its target and JPMorgan remained cautious after the group's third-quarter miss and guidance warning.

Key TakeawaysHaleon shares fell 14% today after it cut its 2026 organic revenue growth outlook to around 2. 5%, from 3%-5%.

The Sensodyne maker plunged after weak cold-and-flu demand, a Chinese import disruption and softer consumer spending forced another cut to its growth outlook.

ASAIY vs. HLN: Which Stock Is the Better Value Option?

Haleon (NYSE:HLN) said its third-quarter performance fell below expectations, citing weaker-than-anticipated North American growth, a softer cough, cold and flu season, a Chinese classification issue affecting Centrum, and continued challenging consumer…

Investing.com -- Haleon (LON:HLN) shares fell sharply on Thursday, hitting a three-week low, after the consumer healthcare group cut its full-year organic revenue growth outlook following weaker-than-expected third-quarter trading, despite announcing a…

Haleon PLC (LSE:HLN, NYSE:HLN) shares fell as much as 14% on Thursday, touching an intraday low of 321p, despite the consumer healthcare group launching a £500 million share buyback programme.

Haleon (LSE:HLN) has drawn fresh attention after appointing Deep Malde as Head of Expert Marketing & Transformation, a move that brings experienced consumer health and brand leadership closer to its extensive over the counter portfolio.

Haleon (LSE:HLN) has appointed Deep Malde as Head of Expert Marketing & Transformation, focusing on its consumer health portfolio.

Haleon has delivered a 20.7% share price return over the past three years, which puts fresh attention on a simple question for you as an investor.

UBS, the Swiss investment bank, says an early rise in flu incidence could lift 2027 earnings forecasts for Reckitt Benckiser Group PLC (LSE:RKT, OTCQX:RBGLY), the consumer goods group, and Haleon, the consumer health group.